BMAL1 and prostate cancer: Genome-wide association studies (GWAS) reveal that variants in BMAL1 are associated with insulin resistance (20, 21), cardiovascular health (21, 22), prostate cancer (23), lung cancer (24), chronotype (25), sociability (26), and neurodegeneration (27).